ribavirin has been researched along with Lichen Planus, Oral in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apostu, D; Campian, RS; Ciobanu, L; Ilea, A; Lucaciu, O; Mester, A | 1 |
| de Aguiar, MC; do Carmo, MA; Grossmann, Sde M; Teixeira, R | 1 |
| Capodiferro, S; Giuliani, M; Lajolo, C; Sartorio, A; Scivetti, M; Tumbarello, M | 1 |
| Bhattacharyya, I; Cohen, DM; Islam, N; Katz, J; Ojha, J; Stewart, CM | 1 |
| Hashimoto, K; Nagao, Y; Sata, M | 1 |
| Ide, T; Kawaguchi, T; Kumashiro, R; Nagao, Y; Sata, M | 1 |
| Jeleń, M; Piszko, P; Simon, K; Sulka, A | 1 |
| Carrozzo, M | 1 |
3 review(s) available for ribavirin and Lichen Planus, Oral
| Article | Year |
|---|---|
Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP.
Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis C; Humans; Inflammation; Interferon-alpha; Lichen Planus, Oral; Liver Diseases; Male; Middle Aged; Prevalence; Ribavirin | 2018 |
Oral lichenoid lesions in HIV-HCV-coinfected subjects during antiviral therapy: 2 cases and review of the literature.
Topics: Antiviral Agents; Diagnosis, Differential; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Lichen Planus, Oral; Lichenoid Eruptions; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Ribavirin | 2008 |
Oral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon Type I; Japan; Lichen Planus, Oral; Mediterranean Region; Mouth Mucosa; Mouth Neoplasms; Recombinant Proteins; Ribavirin; T-Lymphocytes | 2008 |
5 other study(ies) available for ribavirin and Lichen Planus, Oral
| Article | Year |
|---|---|
Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Topics: Aged; Antiviral Agents; Drug Eruptions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lichen Planus, Oral; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Xerostomia and lichenoid reaction in a hepatitis C patient treated with interferon-alpha: a case report.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Hepatitis C; Humans; Interferon-alpha; Lichen Planus, Oral; Male; Middle Aged; Ribavirin; Xerostomia | 2008 |
Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases.
Topics: Adult; Aged; Antiviral Agents; Candidiasis, Oral; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Lichen Planus, Oral; Male; Middle Aged; Polyethylene Glycols; Prevalence; Ribavirin; Salivary Glands; Serum Albumin; Steroids; Stomatitis; Treatment Outcome; Weight Loss | 2012 |
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
Topics: Aged; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Interferons; Leukoplakia; Lichen Planus; Lichen Planus, Oral; Male; Recombinant Proteins; Ribavirin; RNA, Viral; Skin Diseases; Steroids; Time Factors; Transaminases | 2005 |
[The influence of HCV infection and immunomodulating therapy (interferon-alpha and ribavirin) on the condition of minor salivary glands and oral mucosa].
Topics: Adolescent; Adult; Antiviral Agents; Case-Control Studies; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Lichen Planus, Oral; Male; Middle Aged; Ribavirin; Risk Factors; Salivary Gland Diseases; Time Factors | 2005 |